Cell Culture Media for Vaccine Market - by Media Type (Bovine Derived, Porcine Derived, and Animal Free/Serum Free Cell Culture), by Application (Human Vaccine and Animal Vaccine), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
- Report code : CMI12608 |
- Industry :
Biotechnology
- Published On : May 2019 |
- Pages : 197 Pages |
- Format :
Global Cell Culture Media for Vaccine Market – A Novel Approach in Disease Management
Cell culture media for vaccine plays a major role in advanced healthcare, as it regulates the cell cycle. It is the growth medium, available in liquid or gel form, developed to support growth of microorganisms, cells, or small plants.
The global cell culture media for vaccine market size was valued at US$ 1,235.5 million in 2018, and is expected to exhibit a CAGR of 7.7 % over the forecast period (2018 – 2026)
Figure 1. Global Cell Culture Media for Vaccine Market Value (US$ Mn), by Region, 2018
Source: Coherent Market Insights Analysis (2019)
Increasing prevalence of infectious diseases is expected to propel growth of the global cell culture media for vaccine market
High prevalence of infectious diseases is expected to drive the market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), in 2017, around 9,105 tuberculosis cases and around 42,743 cases of lyme disease were reported in the U.S. Also, according to the study conducted by University of Oxford, 2018, the measles cases are currently high in several European countries, where over 82,500 measles cases were registered in Europe in 2018. The number was thrice as compared in 2017, while 15 times in comparison with 2016.
Moreover, increasing availability of innovative bovine blood plasma derivatives is expected to augment the market growth. For instance, in April 2015, Rocky Mountain Biologicals, Inc., a life science and bioprocessing company, launched high-performance Fetal Bovine Serum alternative — Fetalgro. Fetalgro is a proprietary blend of a calf serum base and proprietary additive that matches the Fetal Bovine Serum’s (FBS) cell growth capabilities in CHO, MRC-5, Vero, and a wide range of other cell lines.
However, high risk of contamination is expected to hinder the market growth. The use of serum in vaccine production leads to problems such as the components of bovine serum being carried into the vaccine as a contaminant from the cell culture medium.
Figure 2. Global Cell Culture Media for Vaccine Market Share (%), by Application, 2018 and 2026
Source: Coherent Market Insights Analysis (2019)
Increasing investments by government organizations and manufacturers focusing on promoting immunization in North America is expected to bolster the market growth
The increasing investments by government organizations and manufacturers focusing on promoting immunization is expected to drive the cell culture media for vaccine market. For instance, in 2015, the Centers for Medicare & Medicaid Services (CMS), with the Centers for Disease Control and Prevention (CDC) introduced a five-year initiative, Healthy People 2020 to improve immunization as well as to reduce the disparity rates caused majorly due to pneumonia, shingles, and influenza. The organizations worked directly with physicians and provider offices, home health agencies, hospitals, and beneficiaries under the guidance of Health Service Advisory Group (HSAG) to promote their initiative.
Moreover, increasing number of vaccine clinical trial in the North America is expected to augment the market growth. For instance, in April, 2018, BiondVax Pharmaceuticals Ltd. enrolled participants in the U.S. for a Phase 2 clinical trial of the company’s universal flu vaccine candidate, M-001.
Key Players
Major players operating in the global cell culture media for vaccine market include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE
Cell culture media consists an appropriate source of energy and compounds, which supports growth of cells and regulate the cell cycle. A typical culture medium is composed of vitamins, inorganic salts, complement of amino acids, glucose, and serum which acts as source of growth factors, hormones, and attachment factors. Furthermore, the medium also helps to maintain pH and osmolality.
Market Dynamics
Increasing prevalence of infectious diseases is a major factor driving the global cell culture media for vaccine market growth. According to the Centers for Disease Control and Prevention (CDC), in August 2017, around 104 laboratory-confirmed influenza-associated pediatric deaths were reported, where 66 cases were associated with influenza A viruses and 38 cases were associated with influenza B viruses in the U.S. Moreover, the government initiatives for increasing awareness among the populace regarding prevention of diseases facilitated by vaccines is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.
However, high risk of contamination may hinder the market growth. According to the article published in ResearchGate, 2014, fetal bovine serum (FBS) is known to contain factors such as endotoxins, mycoplasma, viral contaminants, and prions that can lead to bovine spongiform encephalopathy (BSE).
Key features of the study:
- This report provides in-depth analysis of the global cell culture media for vaccine market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights into market drivers, restraints, opportunities, impact analysis, Porter’s analysis, PEST analysis, regulatory scenario, key developments, raw material analysis, and supply chain analysis
- It profiles key players in the global cell culture media for vaccine market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global cell culture media for vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell culture media for vaccine market
Detailed Segmentation:
- Global Cell Culture Media for Vaccine Market, By Media Type:
- Bovine Derived
- Fetal bovine serum (FBS)
- Newborn Calf Serum (NBCS)
- Adult Bovine Serum (ABS)
- Bovine Serum Albumin (BSA)
- Bovine Calf Serum (BCS)
- Porcine Derived
- Animal free/Serum Free Cell Culture
- Global Cell Culture Media for Vaccine Market, By Application:
- Human Vaccines
- Animal Vaccines
- Global Cell Culture Media for Vaccine Market, By Geography:
- North America
- By Media Type:
- Bovine Derived
- Fetal bovine serum (FBS)
- Newborn Calf Serum (NBCS)
- Adult Bovine Serum (ABS)
- Bovine Serum Albumin (BSA)
- Bovine Calf Serum (BCS)
- Porcine Derived
- Animal free/Serum Free Cell Culture
- By Application:
- Human Vaccines
- Animal Vaccines
- By Country:
- U.S.
- Canada
- Latin America
- By Media Type:
- Bovine Derived
- Fetal bovine serum (FBS)
- Newborn Calf Serum (NBCS)
- Adult Bovine Serum (ABS)
- Bovine Serum Albumin (BSA)
- Bovine Calf Serum (BCS)
- Porcine Derived
- Animal free/Serum Free Cell Culture
- By Application:
- Human Vaccines
- Animal Vaccines
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Media Type:
- Bovine Derived
- Fetal bovine serum (FBS)
- Newborn Calf Serum (NBCS)
- Adult Bovine Serum (ABS)
- Bovine Serum Albumin (BSA)
- Bovine Calf Serum (BCS)
- Porcine Derived
- Animal free/Serum Free Cell Culture
- By Application:
- Human Vaccines
- Animal Vaccines
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Media Type:
- Bovine Derived
- Fetal bovine serum (FBS)
- Newborn Calf Serum (NBCS)
- Adult Bovine Serum (ABS)
- Bovine Serum Albumin (BSA)
- Bovine Calf Serum (BCS)
- Porcine Derived
- Animal free/Serum Free Cell Culture
- By Application:
- Human Vaccines
- Animal Vaccines
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Media Type:
- Bovine Derived
- Fetal bovine serum (FBS)
- Newborn Calf Serum (NBCS)
- Adult Bovine Serum (ABS)
- Bovine Serum Albumin (BSA)
- Bovine Calf Serum (BCS)
- Porcine Derived
- Animal free/Serum Free Cell Culture
- By Application:
- Human Vaccines
- Animal Vaccines
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Media Type:
- Bovine Derived
- Fetal bovine serum (FBS)
- Newborn Calf Serum (NBCS)
- Adult Bovine Serum (ABS)
- Bovine Serum Albumin (BSA)
- Bovine Calf Serum (BCS)
- Porcine Derived
- Animal free/Serum Free Cell Culture
- By Application:
- Human Vaccines
- Animal Vaccines
- By Country:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- HiMedia Laboratories *
- Company Overview
- Product Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- General Electric Company
- Sartorius AG
- Proliant, Inc.
- Bovogen Biologicals Pty. Ltd.
- Rocky Mountain Biologicals
- Valley Biomedical
- Moregate BioTech
- Atlanta Biologicals
- Creative-Biolabs
- Life Technologies (India) Pvt Ltd.
- Axil Scientific Pte Ltd.
- Indian Immunologicals Limited
- Serum Institute of India Pvt. Ltd.
- Sisco Research Laboratories Pvt. Ltd.
- Valneva SE
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Media Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Porter’s analysis
- PEST analysis
- Regulatory Scenario
- Key Developments
- Raw material analysis
- Supply chain analysis
- Global Cell Culture Media for Vaccine Market, By Media Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Bovine Derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Fetal bovine serum (FBS)
- Newborn Calf Serum (NBCS)
- Adult Bovine Serum (ABS)
- Bovine Serum Albumin (BSA)
- Bovine Calf Serum (BCS)
- Porcine Derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Animal free/Serum Free Cell Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Global Cell Culture Media for Vaccine Market, By Application, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Human Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Animal Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Global Cell Culture Media for Vaccine Market, By Region, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- HiMedia Laboratories
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck KGaA
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- General Electric Company
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sartorius AG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Proliant, Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bovogen Biologicals Pty. Ltd.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Rocky Mountain Biologicals
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Valley Biomedical
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Moregate BioTech
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Atlanta Biologicals
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Creative-Biolabs
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Life Technologies (India) Pvt Ltd.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Axil Scientific Pte Ltd.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Indian Immunologicals Limited
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Serum Institute of India Pvt. Ltd.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Valneva SE
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 33 market data tables and 27 figures on “Cell Culture Media for Vaccine Market - Global forecast to 2026”.
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.